- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Jeff Dale2024-05-16T18:52:00
Evoqua Water Technologies agreed to pay $8.5 million as part of a nonprosecution agreement (NPA) with the Department of Justice (DOJ) to settle admitted criminal charges related to fraudulent revenue recognition.
Evoqua, which designs industrial wastewater treatment and filtration plants, was headquartered in Pennsylvania. Its aquatics and disinfection (A&D) division was based in Rhode Island, where the misconduct took place, the DOJ said in a press release Tuesday.
In March 2023, the company settled its civil liabilities related to the same misconduct with the Securities and Exchange Commission (SEC) by agreeing to pay a separate $8.5 million penalty. Evoqua also paid nearly $16.7 million to settle a shareholder class-action lawsuit over the same misconduct.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
China-based technology company Cloopen Group Holding won’t pay a fine in settling with the Securities and Exchange Commission over an alleged accounting fraud scheme perpetrated by two of its former senior managers.
Electronic payments software company Cantaloupe agreed to pay a $1.5 million penalty to settle allegations of accounting fraud levied by the Securities and Exchange Commission arising from improper revenue recognition practices.
Evoqua Water Technologies Corp. agreed to pay $8.5 million to resolve charges the actions of a former company finance director led the firm to misstate its revenue in filings with the Securities and Exchange Commission.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
